Real-World Data Show Lecanemab Is Mostly Safe but Flag a Stroke Signal
A combined real-world cohort and FAERS analysis finds lecanemab generally safe in Alzheimer's patients but flags a strong, unlabeled signal ...
A combined real-world cohort and FAERS analysis finds lecanemab generally safe in Alzheimer's patients but flags a strong, unlabeled signal ...
A new multimodal AI framework called MEGH-DDI combines chemical language models with graph neural networks to predict drug–drug interactions with ...
A retrospective Chinese cohort study reports rare but serious cardiovascular toxicity, including heart failure and QTc prolongation, in patients with ...
A new systematic review of 15 studies confirms semaglutide's clinically meaningful weight-loss benefits while cautioning that results vary by dose, ...
A regulator-mandated study using nationwide registry data from Denmark, Sweden and Norway found no increased risk of pancreatic cancer among ...
A new narrative review repositions methotrexate as a complementary, steroid-sparing option in Still's disease while confirming that early interleukin-1 or ...
A new systematic review finds that phosphodiesterase-4 inhibitors achieved clinical response in 53.4 percent of hidradenitis suppurativa patients with a ...
A multicenter study of 104 patients finds that lower-dose and higher-dose bevacizumab produce similar radiographic outcomes in brain radiation necrosis, ...
A new meta-analysis of twenty studies covering nearly 292,000 people finds that long-term metformin use is significantly associated with peripheral ...
A new machine learning method called DCSE predicts side effects of drug combinations and introduces more realistic evaluation standards that ...
A global pharmacovigilance analysis of 354 pregnancies found no unexpected safety signals with the complement inhibitor ravulizumab, with outcomes consistent ...
A two-stage analysis combining FDA adverse event reports with Japanese claims data found aripiprazole associated with a significantly lower risk ...
A 608-patient multicenter study in China found that delamanid-containing regimens for multidrug-resistant tuberculosis showed a safety profile consistent with clinical ...
A nationally representative Swiss survey finds that 2.5 percent of the population has used GLP-1 receptor agonists, mostly for weight ...
A new meta-analysis of six randomized controlled trials finds that the 36 mg maintenance dose of the oral GLP-1 agonist ...
A large retrospective cohort study of 505 meta-analyses finds that most early evidence on medication harms expires within about three ...
A new genetics-based framework systematically flags potential safety risks for inflammatory bowel disease drug targets before broad clinical exposure.
A meta-analysis of twenty-three studies covering nearly 1.83 million women finds that short-term SSRI use is associated with a modest ...
A 15-year analysis of 454 herbal medicine adverse event reports at a Korean integrative medical center shows that nearly a ...
Researchers at the University of Catania have built a modular computational framework that ranks RNA-lipid nanoparticle formulations for safety and ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.